0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.190.232. Please contact the publisher to request reinstatement.
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2006;295(17):1973. doi:10.1001/jama.295.17.1973.
Text Size: A A A
Published online

COMBINATION THERAPY FOR ALCOHOL DEPENDENCE

The efficacies of medication and behavioral therapies, alone or in combination, for treating alcohol dependence were assessed in the multicenter randomized Combined Pharmacotherapies and Behavioral Interventions (COMBINE) study, in which study participants were randomly assigned to 1 of 9 treatment groups. Eight of the groups included medical management plus naltrexone or acamprosate, both medications, or placebos, for 16 weeks, and with or without a combined behavioral intervention (CBI). A ninth group received CBI alone. Anton and colleaguesArticle writing for the COMBINE study investigators report that patients in all groups had an increased number of days of abstinence. However, patients receiving naltrexone, CBI, or both along with medical management had more days of abstinence and fewer heavy drinking days than patients in other treatment groups. Acamprosate did not appear to be efficacious in this study. In an editorial, KranzlerArticle discusses the treatment of alcohol dependence.

WALK PERFORMANCE, MORTALITY, AND MORBIDITY

In a cohort of community-dwelling adults who were aged 70 to 79 years and had no apparent mobility limitations, Newman and colleagues examined the association of baseline performance on a 400-m corridor walk test with total mortality, incident cardiovascular disease, and incident mobility limitation and disability during 4.9 years of follow-up. The authors found that not completing the test or taking a longer time for completion than other patients predicted the occurrence of these adverse events during follow-up.

INCOME AND HEALTH CARE AMONG THE UNINSURED

To assess whether having a higher income attenuates the association between being uninsured and receiving fewer recommended health services than insured persons in the United States, Ross and colleagues examined data from a 2002 nationally representative survey. They found that persons without health insurance were less likely to use recommended cancer prevention, cardiovascular risk reduction, and diabetes management services compared with persons having insurance. Higher income did not attenuate the difference.

DISEASE, DISADVANTAGE IN THE UNITED STATES AND ENGLAND

Whether higher per capita health care expenditures are associated with better health outcomes is not known. Using nationally representative data from the United States and England, Banks and colleagues compared biological disease markers and self-reported disease prevalence rates for non-Hispanic whites aged 55 to 64 years in the 2 countries. The authors found that despite higher expenditures on health, persons in the United States reported more disease and had more adverse biological disease markers than persons in England at all levels of education and income.

EARLY STATIN THERAPY AND OUTCOMES IN ACS

Long-term statin therapy benefits patients with cardiovascular disease risks, but whether early statin therapy can improve outcomes in patients with recent acute coronary syndromes (ACS) is not clear. Briel and colleagues conducted a meta-analysis of data from 12 clinical trials that compared early outcomes of patients with ACS who were randomly assigned to receive statin therapy within 14 days of the event vs placebo or usual care. The authors found no evidence that early initiation of statins reduces death, nonfatal myocardial infarction, or stroke in the immediate 4 months after ACS.

A PIECE OF MY MIND

“His dramatic stories and gestures, the musicality of his speaking voice, his larger-than-life facial expressions . . . one could describe them all as ‘operatic.’” From “A Glimpse Backstage.”

MEDICAL NEWS & PERSPECTIVES

To limit the exchange of infectious agents between animals and humans, a key precursor to many pandemics, infectious disease experts have launched efforts to monitor emerging diseases in domestic and wild animals.

CLINICIAN'S CORNER

Several nonhormonal therapies demonstrate modest efficacy for reducing the frequency and severity of menopausal hot flashes. In an editorial, Tice and Grady discuss the pathophysiology of hot flashes, treatment efficacy, and safety.

DRUG SAFETY

Strom discusses limitations of the current system for monitoring drug safety and suggests an alternate approach.

AUDIO COMMENTARY

Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl.

JAMA PATIENT PAGE

For your patients: Information about alcohol abuse and alcoholism.

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...